Complexo Hospitalario Universitario de Ourense
Centro asistencial
Hospital Royo Villanova
Zaragoza, EspañaPublicacións en colaboración con investigadores/as de Hospital Royo Villanova (11)
2024
-
Psoriasis induced by antiTNF therapy in inflammatory bowel disease: Therapeutic management and evolution of both diseases in a nationwide cohort study
Digestive and Liver Disease, Vol. 56, Núm. 12, pp. 2060-2068
-
Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA
Clinical Gastroenterology and Hepatology, Vol. 22, Núm. 11, pp. 2280-2290
2022
2021
-
Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation
BMC Cardiovascular Disorders, Vol. 21, Núm. 1
-
Epidemiology and prognosis of patients with a history of cancer admitted to intensive care. A multicenter observational study
Medicina Intensiva, Vol. 45, Núm. 6, pp. 332-346
-
Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study
Journal of Clinical Medicine, Vol. 10, Núm. 13
2019
-
Quality of life, adherence and satisfaction of patients with auricular fibrillation treated with dabigatran or vitamin K antagonists
Revista Clinica Espanola, Vol. 219, Núm. 6, pp. 285-292
2018
-
Risk factors for unfavourable postoperative outcome in patients with Crohn's disease undergoing right hemicolectomy or ileocaecal resection. An international audit by ESCP and S-ECCO
Colorectal Disease, Vol. 20, Núm. 3, pp. 219-227
2016
-
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome
Critical Care, Vol. 20, Núm. 1
2011
2010
-
Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype
Gastroenterology, Vol. 139, Núm. 3